These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


202 related items for PubMed ID: 3014736

  • 21. [The role of the antithrombin III-heparin-thrombin complex in the defense reaction of the anticoagulation system].
    Kudriashov BA, Liapina LA, Pastorova VE.
    Vopr Med Khim; 1988; 34(2):38-42. PubMed ID: 3400189
    [Abstract] [Full Text] [Related]

  • 22. [Comparative study of the properties of a fibrinogen--heparin complex produced in vitro and one isolated from a plasma fraction of fibrinogen degradation products].
    Kudriashov BA, Liapina LA, Zhitnikova ES, Kriukova MG.
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1979; (9):58-62. PubMed ID: 497299
    [No Abstract] [Full Text] [Related]

  • 23. Kinetic study on the initial stage of the fibrinogen-fibrin conversion by thrombin. (IV). Effects of heparin and its analogues.
    Sato H, Nakajima A, Shimohira T.
    Thromb Res; 1985 Sep 01; 39(5):549-57. PubMed ID: 4082100
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Real-time measurement of free thrombin: evaluation of the usability of a new thrombin assay for coagulation monitoring during extracorporeal circulation.
    Krajewski S, Krauss S, Kurz J, Neumann B, Schlensak C, Wendel HP.
    Thromb Res; 2014 Mar 01; 133(3):455-63. PubMed ID: 24359968
    [Abstract] [Full Text] [Related]

  • 26. [Delay in thrombin clearance as a diagnostic test of prethrombosis in depression of the anticoagulation system caused by atherogenic diet].
    Kudriashov BA, Bagaz'ian GG, Ul'ianov AM, Liapina LA, Sytina NP.
    Vopr Med Khim; 1976 Mar 01; 22(6):736-40. PubMed ID: 1027248
    [Abstract] [Full Text] [Related]

  • 27. [Effect of a complex mixture of plasma proteins with heparin on the anticoagulation and fibrinolytic activity of the blood plasma in animals following intravenous administration of tissue thromboplastin].
    Pastorova VE.
    Fiziol Zh SSSR Im I M Sechenova; 1988 Jun 01; 74(6):814-9. PubMed ID: 3181520
    [Abstract] [Full Text] [Related]

  • 28. The glycosaminoglycan of recombinant human soluble thrombomodulin affects antithrombotic activity in a rat model of tissue factor-induced disseminated intravascular coagulation.
    Nawa K, Itani T, Ono M, Sakano K, Marumoto Y, Iwamoto M.
    Thromb Haemost; 1992 Mar 02; 67(3):366-70. PubMed ID: 1322570
    [Abstract] [Full Text] [Related]

  • 29. [Role of heparin in the process of blood coagulation and fibrinolysis].
    Liapina LA.
    Usp Sovrem Biol; 1977 Mar 02; 84(3):338-52. PubMed ID: 343416
    [No Abstract] [Full Text] [Related]

  • 30. The fibrinogenolytic activity of purified tryptase from human lung mast cells.
    Schwartz LB, Bradford TR, Littman BH, Wintroub BU.
    J Immunol; 1985 Oct 02; 135(4):2762-7. PubMed ID: 3161948
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A kinetic study on the effects of anticoagulants on the interaction of fibrinogen and thrombin.
    Nakanishi E, Sato H, Nakajima A.
    J Biomed Mater Res; 1987 Feb 02; 21(2):187-200. PubMed ID: 2434508
    [Abstract] [Full Text] [Related]

  • 33. Placental protein 5 (PP5) inhibits thrombin-induced coagulation of fibrinogen.
    Meisser A, Bischof P, Bohn H.
    Arch Gynecol; 1985 Feb 02; 236(4):197-201. PubMed ID: 4026390
    [Abstract] [Full Text] [Related]

  • 34. Interaction of the 268-282 region of glycoprotein Ibalpha with the heparin-binding site of thrombin inhibits the enzyme activation of factor VIII.
    De Cristofaro R, De Filippis V.
    Biochem J; 2003 Jul 15; 373(Pt 2):593-601. PubMed ID: 12689334
    [Abstract] [Full Text] [Related]

  • 35. On the interaction of heparin-containing polymers with plasma proteins and blood.
    Platé NA, Valuev LI.
    Thromb Res; 1982 Jul 15; 27(2):131-41. PubMed ID: 7135350
    [Abstract] [Full Text] [Related]

  • 36. [Effect of fibronectin on fibrinogen conversion into fibrin].
    Litvinov RI, Zubairov DM.
    Biokhimiia; 1988 Jul 15; 53(7):1203-13. PubMed ID: 3179367
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
    Gravlee GP, Haddon WS, Rothberger HK, Mills SA, Rogers AT, Bean VE, Buss DH, Prough DS, Cordell AR.
    J Thorac Cardiovasc Surg; 1990 Mar 15; 99(3):518-27. PubMed ID: 2308370
    [Abstract] [Full Text] [Related]

  • 40. Reversal of dabigatran anticoagulation ex vivo: Porcine study comparing prothrombin complex concentrates and idarucizumab.
    Honickel M, Treutler S, van Ryn J, Tillmann S, Rossaint R, Grottke O.
    Thromb Haemost; 2015 Apr 15; 113(4):728-40. PubMed ID: 25567155
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.